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INTRODUCTION 
Orthopaedic extremity injuries present a large medical and financial 
burden to the United States and world-wide communities [1].  
Approximately six million long bone fractures are reported annually in 
the United States and approximately 10% of these fractures do not heal 
properly.  Though the exact mechanism of impaired healing is poorly 
understood, many of these non-unions result when there is a 
communited condition that does not proceed through a stabilized 
healing pathway [2]. Currently, clinicians may monitor healing 
visually by radiographs, or via manual manipulation of the bone at the 
fracture [3]. Unfortunately, the course of aberrant fracture healing is 
not easily diagnosed in the early period when standard radiographic 
information of the fracture is not capable of discriminating the healing 
pathway.  Manual assessment of fracture healing is also an inadequate 
diagnostic tool in the early stages of healing [4].  
 To overcome these shortcomings, we have developed a radio 
frequency (RF) strain sensor design that takes advantage of advances 
in micro-electro-mechanical systems (MEMS) technology.  The 
inductively-powered sensor is intended to monitor the surface bending 
strains on implanted hardware. Our prior work has included analytical 
and numerical analyses including RF finite element simulations and 
prototype fabrication that demonstrate the feasibility of our proposed 
approach [5,6].  Currently, second generation prototypes are being 
fabricated that represent fine tuning of the sensor geometry to enhance 
the signal quality and sensitivity.  Prior to applied studies numerous 
challenges must be overcome if MEMS devices are to be successfully 
implemented for implantable medical applications. To date, the safety 
and performance of the materials that constitute our bioMEMS sensor 
have not been investigated.  Thus, the scope of the current study was 
to investigate the site-specific biocompatibility and wound-healing 
response elicited against this novel device in a small animal model. 
MATERIALS AND METHODS 
MEMS Materials & Sensor Development 
The bioMEMS sensor investigated here is designed and implemented 
in spiral architecture (Fig. 1). Its Si3N4 dielectric film is deposited on a 
silicon substrate by PECVD (plasma enhanced chemical vapor 
deposition). Subsequently, by photolithography and metal deposition, 
gold is deposited on Si3N4 to finalize sensor fabrication. Sensor design 
parameters are presented in Table 1, where Lc and Wc are the total 
length and width of the device, N is the number of turns, w is the coil 
width, s is spacing between the segments in the spiral coil, tfilm is the 
thickness of the dielectric layer, and t is the thickness of the metal 
layer.  
 In operation, this bioMEMS sensor exhibits a characteristic 
resonance frequency. By applying external loads to the device in a 
controlled fashion, the resonance frequency shifts as a result of 
deformation of the area of the dielectric layer under the applied load, 
leading to a large change in the capacitance of the device. By 
measuring the shift in resonance frequency, information on the load 
carried by the implanted fracture fixation plate, and thus insights into 
the progression of fracture healing, can be obtained. Preliminary ex 
vivo data aside, we have yet to rigorously address the issue of 
biocompatibility of our bioMEMS device. 
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Fig. 1. Top-view micrograph of our 
fabricated bioMEMS sensor. 
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Biocompatibility Experimental Design 
New Zealand White Rabbits were chosen as an appropriate animal 
model because of their size and ability to house multiple bioMEMS 
chips. A total of four rabbits each implanted with 4 MEMS devices 
and 2 control material implants (6 implants/rabbit; 16 MEMS and 8 
controls total) were used to investigate the biocompatibility of the 
device in accordance with ASTM Standards F981-04 and F763-04. 
Animals were humanely euthanized six months post-operatively at 
which time critical gross pathology and microscopic evaluation of the 
implant sites for an implant-associated tissue reaction was pursued. 
 
Surgical Procedure 
Prior to surgery, implant materials were sterilized via two cycles of 
autoclave for 25 min/10 min dry at 121°C. The surgical sites were 
denuded of all hair on both sides of the spinal column. The skin was 
swabbed lightly with diluted alcohol and dried prior to sample 
implantation. Each rabbit received six (n=6) sterilized samples (four 
test materials and two controls) each implanted in individual sites of 
the lumbar paravertebral musculature. Two bioMEMS chips (5 mm x 
5 mm) and one control specimen (aluminum oxide, Al2O3; ASTM 
F603-00(2000)) were placed parallel to and on either side of the spinal 
column approximately 2.5 to 5 from midline and 2.5 cm apart from 
each other resulting in a total of 3 implants per side.   
 
Euthanasia and Implant Site Analysis 
Animals were euthanized six months postoperatively by intravenous 
injection of sodium pentobarbital. The tissue surrounding and 
overlying each implant, both for bioMEMS test material and the Al2O3 
control material, was macroscopically evaluated for evidence of 
internal and external lesions in accordance with a semi-quantitative 
scoring system developed in our laboratory. Each implant was then 
removed with an intact envelope (~ 4 mm) of surrounding tissue and 
fixed for 24 hours in 10% neutral buffered formalin. After fixation, 
each implant was removed from the tissue envelope and the tissue 
specimens were routinely processed, embedded in paraffin, sectioned 
at 5 µm, and stained with Hematoxylin and Eosin (H&E) for semi-
quantitative evaluation of the cellular and tissue response to the 
bioMEMS and control materials. Microscopic evaluation was 
performed by a single board certified pathologist (D.A.K.) blinded to 
the treatment groups so as to avoid observer bias. 
 
RESULTS 
During convalescence, there were no complications resulting from the 
surgical procedure, no evidence of post-operative infection, and no 
mortality in the six-month survival period.  At euthanasia, gross 
examination of tissue adjacent to the bioMEMS materials did not 
reveal any visible signs of adverse reactions manifested as external or 
internal lesions to the test materials.  No infection or inflammation was 
grossly noted in the musculature surrounding implanted materials. 
 Microscopic examination of the H&E stained slides confirmed 
that there was no adverse tissue reaction to the bioMEMS materials 
either immediately adjacent to or peripheral to the implantation site 
(Fig. 2). Examination of histological slides confirmed the absence of 
abnormal macrophage or lymphocytic cellular activity. Resultantly, 
inflammation scores for the bioMEMS and Al2O3 control materials 
were 0 ± 0 and 0 ± 0 (mean ± stdev), respectively.  Minimal fibrosis 
was noted surrounding both the control and bioMEMS materials (1.0 ± 
0.5 and 0.94 ± 0.24, respectively) and the general toxicity score for the 




Monitoring real-time fracture healing in vivo using MEMS technology 
is an attractive alternative to traditional radiographic and physical 
manipulation modalities as the implantable sensor output is 
quantitative in nature and far less subjective.  However, prior to 
applied clinical studies, baseline biocompatibility of the implantable 
sensor must be thoroughly investigated and established.  Using a rabbit 
model, Kotzar et al. [7] demonstrated that the common materials used 
in the construction of MEMS sensors, including silicon (Si), silicon 
dioxide (SiO2), and silicon nitride (Si3N4), do not exhibit a quantifiable 
adverse tissue response after 12 weeks in vivo. Given that complex 
tibial fractures, for example, may take up to six months to heal 
completely, to monitor the complete course of osseous healing, 
implantable devices may be required to both function appropriately 
and demonstrate adequate biocompatibility for greater than 24 weeks 
in the body.  Thus the present study sought to build on the previous 
work by focusing on the long-term biocompatibility of our bioMEMS 
device in sites relevant for a clinical application.  
 The preliminary results presented here demonstrate the site-
specific biocompatibility of the MEMS materials that we propose for 
use in monitoring bending strains on internal fixation devices that 
stabilize and promote fracture repair.  Though these preliminary 
results are encouraging, additional studies are still required to 
definitively characterize the tissue responses that would be induced by 
our MEMS device in an osseous wound site as well as ensure 
continued sensor functionality in vivo for time periods similar to those 
required for complex fracture healing. 
 
CONCLUSION 
The findings presented here support further development and 
characterization of a fracture healing monitoring system based on 
implantable MEMS devices. 
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Table 1. 
bioMEMS Sensor Design Parameters.
Lc  (µm) Wc  (µm) N w  (µm) s  (µm) t film  (µm) t (µm)
900 900 2 100 100 0.1 0.1
Fig 2.  2x (A) and 4x (B) images of the H&E stained tissue 
adjacent to the implanted MEMS sensor.  After six months, no 
evidence of inflammation or adverse tissue response was 
documented adjacent to any of the implanted MEMS materials.
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